ライフサイエンスコーパス: small bowel transplantation

1 llected samples taken from 27 patients after small bowel transplantation.

2 D is a fatal and progressive complication of small bowel transplantation.

3 arly posttransplant outcome after orthotopic small bowel transplantation.

4 possible because of parenteral nutrition and small bowel transplantation.

5 munosuppression for kidney, liver, lung, and small bowel transplantation.

6 Severe skin problems are uncommon after small bowel transplantation.

7 rtant in mediating enteric dysfunction after small bowel transplantation.

8 ng tissue damage and improving outcome after small bowel transplantation.

9 red for consideration for combined liver and small bowel transplantation.

10 on the incidence of GVHD and rejection after small bowel transplantation.

11 with inhibition of allograft rejection after small bowel transplantation.

12 dies after allogeneic and semiallogeneic rat small bowel transplantation.

13 tinal failure can then be referred for early small bowel transplantation.

14 volution of acute rejection in this model of small bowel transplantation.

15 gistic effect in preventing allorejection of small bowel transplantation.

16 t rejection in selected settings in clinical small bowel transplantation.

17 this review deals with the current status of small-bowel transplantation.

18 Advances in small bowel transplantation are also reported.

19 The advantages over combined liver and small bowel transplantation are clear: organ availabilit

20 Pediatric small bowel transplantations are associated with pronoun

21 s obtained from adult patients who underwent small bowel transplantation at the University of Pittsbu

22 We reviewed 11 small bowel transplantations between October 2002 and Fe

23 Small bowel transplantation can be a life-preserving pro

24 re necessary before a broader application of small bowel transplantation can be indicated.

25 imultaneously induced after fully allogeneic small bowel transplantation, despite rejection being the

26 , a child with this syndrome underwent liver-small bowel transplantation from a 1-of-6 HLA-matched do

27 We analyzed prospective data of 51 primary small bowel transplantations from December 1999 to Augus

28 Small bowel transplantation has been limited by high rat

29 The evolution of small bowel transplantation has been significant over th

30 Small bowel transplantation has now become a recognized

31 We hypothesized that, following experimental small bowel transplantation, immunosuppressive therapy i

32 LA4Ig therapy in preventing allorejection of small bowel transplantation in high-responder Lewis rat

33 has a role as a conservative alternative to small bowel transplantation in patients with SBS permane

34 ent, a 33-year-old Hispanic woman, underwent small-bowel transplantation in December, 1994.

35 Small bowel transplantation is a successful treatment fo

36 r isolated small bowel or combined liver and small bowel transplantation is approximately 50% at 5 ye

37 Small bowel transplantation is complicated by diarrhea a

38 offering autologous bowel reconstruction and small bowel transplantation is discussed.

39 The most common application of small bowel transplantation is for the patient with pare

40 Primary abdominal wall closure following small bowel transplantation is frequently impossible due

41 Ileal motility after small bowel transplantation is poorly characterized.

42 The management of small bowel transplantation is unique because signs of r

43 se of sequential combined living donor liver/small bowel transplantation (LDL/SBT).

44 More recently, living related small bowel transplantation (LR-SBTx) has been developed

45 on of phenobarbital treatment and orthotopic small bowel transplantation may be an appropriate therap

46 ombined heart-kidney, heart-liver, and heart-small bowel transplantation models.

47 t did not prevent, allograft rejection after small bowel transplantation of ACI into Lewis rats.

48 Small bowel transplantation provides a potentially life-

49 continuous improvement of immunosuppression, small bowel transplantation (SBT) is plagued by a high i

50 valence of adenoviral infection in pediatric small bowel transplantation (SBT) recipients, examine ri

51 On the basis of our experience with rat small bowel transplantation (SBT), we established a mode

52 the areas of short bowel syndrome (SBS) and small bowel transplantation (SBT).

53 disease (GVHD) occurs in the recipient after small bowel transplantation (SBT).

54 re responsible for the dysmotility following small bowel transplantation (SBTX) are incompletely unde

55 More than 60% children with small bowel transplantation (SBTx) experience acute cell

56 ith biopsy is currently the gold standard of small bowel transplantation (SBTx) monitoring, however i

57 tion affects more than 60% of children after small bowel transplantation (SBTx).

58 and may serve as markers of rejection-prone small bowel transplantation (SBTx).

59 high incidence of infections occurring after small bowel transplantation (SBTx).

60 experimental model of allogeneic heterotopic small bowel transplantation (SBTx).

61 lly, FK506 is superior to CsA after solitary small bowel transplantation (SBTx).

62 ts with severe cutaneous complications after small bowel transplantation, the work-up, final diagnosi

63 Small bowel transplantation was performed between rats t

64 s also prolonged when simultaneous heart and small bowel transplantation was performed in anti-CD4-tr

65 Orthotopic small bowel transplantation was performed using an allog

66 graft-versus-host disease (GvHD) heterotopic small bowel transplantation was performed using DA, PVG,

67 Between August 2008 and October 2014, 29 small bowel transplantations were performed in 28 patien

68 d sepsis can be intimately related following small bowel transplantation when rejection compromises n

69 ent total enterectomy followed by orthotopic small bowel transplantation with or without the colon.